Company intelligence / Profile preview

PRLA Pharma

Azerbaijan

Ownership: Private
Employees: ~23
Development stage: Other

Overview

Parla Pharmaceuticals is Azerbaijan’s first science-based pharmaceutical company, focused on the full production of high-technology medicines, including biotechnological and nanotechnological innovations. The company is commercially active, with products available in all pharmacies and online in Azerbaijan. Parla emphasizes affordability, quality, and innovation, and is committed to corporate social responsibility and environmental sustainability[1][2][4].

Modalities: BiologicSmall moleculeNanoparticle
Industry: Biotech

Beyond the preview

Go deeper on PRLA Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRLA Pharma.

Explore the full profile